(1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts) | 2710 |
(2) Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester) | 2720 |
(3) Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester] | 2779 |
(4) Ganaxolone (3[ALPHA]-hydroxy-3[BETA]-methyl-5[ALPHA]-pregnan-20-one) | 2401 |
(5) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide] | 2746 |
(6) Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide] | 2790 |
(7) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] | 2782 |